Home > Insider Trading > Filing (0001493152-20-010852)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1433607	Inspiremd Inc.	NSPR	Surgical & Medical Instruments & Apparatus (3841)	262123838

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1796908	Marvin Slosman	C/O Inspiremd, Inc. 4 Menorat Hamaor St. Tel Aviv L3 6744832	Ceo And President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-06-05	55,550	$0.45	237,931	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants	Acquisiton	2020-06-05	55,550	$0.45	55,550	$0.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
55,550	2020-06-05	2025-06-02	No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Options (right to buy)	$1.10		2030-01-02	60,794	60,794	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2030-01-02	60,794	60,794	Direct

Footnotes

The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 55,550 shares of common stock and 55,000 warrants to purchase common stock together, as part of 55,000 units, at a purchase price of $0.45 per unit.
182,381 of these shares of common stock represent restricted stock units ("RSUs"), which vest in three equal annual installments, with 1/3 vesting on each of January 2, 2021, January 2, 2022 and January 2, 2023, subject to the Reporting Person's continued service.
The Reporting Person has not engaged in any reportable transactions with respect to the derivative securities of the Issuer reported in this row and is including his ownership of these securities for informational purposes only in this Form 4.
These stock options vest in three equal annual installments, with 1/3 vesting on each of January 2, 2021, January 2, 2022 and January 2, 2023, subject to the Reporting Person's continued service.